The high-performing, concurrent-read, cancer detection, and workow solution rapidly analyze each tomosynthesis image accurately, detecting both malignant soft-tissue densities and calcifications with unrivaled accuracy. Built on the latest deep learning and artificial intelligence technology, ProFound AI for breast tomosynthesis is clinically proven to assist radiologists in addressing the challenges of reading tomosynthesis cases by:

• Improving cancer detection rates
• Reducing false positives and unnecessary patient recalls
• Decreasing reading times

Digital breast tomosynthesis (DBT) is rapidly replacing 2D mammography in breast cancer screening because of the clinical value it offers in cancer detection. However, it presents significant workload challenges for radiologists, which can affect patient care.

ProFound AI™ is clinically proven to assist radiologists by improving cancer detection, decreasing reading times, and reducing false positives and costly patient recalls. ProFound AI for digital breast tomosynthesis runs on the industry-leading PowerLook server platform with NVIDIA Graphical Processing Units (GPU).

Facebook Page of the Solution

Twitter Page of the Solution

linkedin Page of the Solution

Website of the Solution